Related Experiment Video
Updated: Jun 16, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Implications of Cheyne-Stokes breathing in advanced systolic heart failure
Offer Amir1, Daniel Reisfeld, Hila Sberro
1Department of Cardiology, Lin Medical Center and Lady Davis Carmel Medical Center, Yocheced 10 street, Haifa, Israel. offeram@012.net.il
Insights
Cheyne-Stokes breathing (CSB) is highly prevalent in advanced heart failure (HF) patients. Longer CSB duration correlates with higher NT-proBNP levels and increased 6-month mortality, indicating its prognostic significance.
Area of Science:
- Cardiology
- Sleep Medicine
- Pulmonology
Background:
- Cheyne-Stokes breathing (CSB) is a known phenomenon in heart failure (HF) patients.
- Its exact prevalence and prognostic impact in advanced HF remain unclear.
Purpose of the Study:
- To determine the prevalence of nocturnal CSB in advanced HF.
- To investigate the association between CSB and prognostic indicators, including mortality.
Main Methods:
- Ambulatory polysomnography was conducted on 71 advanced systolic HF patients.
- Sleep data, clinical information, and 6-month mortality were analyzed.
Main Results:
- All patients exhibited CSB, with a mean duration of 1 hour.
- CSB duration significantly correlated with elevated NT-proBNP levels (r=0.5, P<.0001).
- Kaplan-Meier analysis revealed a significant association between CSB duration and 6-month mortality (P=.03).
Conclusions:
- Nocturnal CSB is highly prevalent in advanced HF, exceeding prior estimates.
- CSB duration is a significant predictor of elevated NT-proBNP and increased 6-month mortality in this population.
Background:
Cheyne-Stokes breathing (CSB) has been associated with heart failure (HF) patients for many years; however, its true prevalence and its prognostic implications are still obscure.
Hypothesis:
The goal of this study was to investigate the prevalence and the possible prognostic implications of nocturnal CSB in advanced heart failure patients.
Methods:
We performed single night full polysomonography ambulatory sleep studies in 71 HF patients. We analyzed the patients' sleep studies, clinical and laboratory data, and 6 month mortality.
Results:
A total of 71 chronic systolic HF patients were analyzed, 60 males, 11 females, age 65 +/- 13 years. Mean left ventricular ejection fraction was 27% +/- 11%. Short episodes of CSB (at least 3 min duration) were present in all patients, and mean CSB duration was 1 hour. CSB duration was associated significantly with both high serum levels of N-terminal prohormone brain natriuretic peptide (NT-proBNP) as well as with 6 month mortality. Log CSB time had a significant correlation with log NT-proBNP (r = 0.5, P<.0001). Based on median CSB duration, the Kaplan-Meier survival curve analysis showed significant association with 6 month mortality (P = .03).
Conclusions:
CSB prevalence in advanced HF patients is higher than previously reported and is associated with increased serum levels of NT-proBNP and higher 6 month mortality.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes include...
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Acute Respiratory Failure-IV
Heart Failure III: Clinical Manifestations
